Transforming big pharma : assessing the strategic alternatives / John Ansell.
2013
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Author
Uniform Title
Ebrary electronic monographs.
Title
Transforming big pharma : assessing the strategic alternatives / John Ansell.
Added Corporate Author
Imprint
Farnham, Surrey : Gower Pub. Ltd., 2013.
Description
xvi, 265 pages : illustrations
Formatted Contents Note
pt. I. How pharma differs and why this is important
pt. II. Assessing management concepts for the pharmaceutical industry
pt. III. Big pharma's strategic options
pt. IV. Where will new products come from?
pt. V. Prospects for new products
pt. VI. Getting a true fix on prospects
pt. VII. Conclusions and summary.
pt. II. Assessing management concepts for the pharmaceutical industry
pt. III. Big pharma's strategic options
pt. IV. Where will new products come from?
pt. V. Prospects for new products
pt. VI. Getting a true fix on prospects
pt. VII. Conclusions and summary.
Bibliography, etc. Note
Includes bibliographical references and index.
Linked Resources
Language
English
Reproduction
Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
ISBN
9781409448273 hardcover alkaline paper
9781409448280 e-book
9781409448280 e-book
Record Appears in